NCT05007366

Brief Summary

The purpose of this study is to report the feasibility and determine the initial effects of 18 sessions of real-time gait biofeedback delivered over a 6-week period on retention and transfer of normalized gait biomechanics and improvements in indicators of early post-traumatic osteoarthritis development in those with an anterior cruciate ligament reconstruction (ACLR) at 6 and 8-week posttests.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 5, 2021

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 12, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 16, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2022

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

1.3 years

First QC Date

August 12, 2021

Last Update Submit

April 14, 2023

Conditions

Keywords

Biofeedback

Outcome Measures

Primary Outcomes (6)

  • Number of participants recruited using different recruitment modes

    The investigators will record the number of participants who were recruited, the frequency at which they were recruited, and where they were recruited from. Range 0-70. Higher number indicates more completion.

    Baseline (pre-intervention)

  • The frequency of participant recruitment using different recruitment modes

    The investigators will record the number of participants who were recruited, the frequency at which they were recruited, and where they were recruited from. Range 0-70. Higher number indicates more completion.

    Baseline (pre-intervention)

  • Percentage of participants who were successfully enrolled

    The investigators will record the number of participants who were successfully enrolled compared to the total number of participants screened. Range: 0-100. Higher percentage indicates more enrollment.

    Baseline (pre-intervention)

  • Percentage of participants retained

    Investigators will record the percentage of patients retained at each monthly data capture timepoint.

    After week 4 and after week 8

  • Reasons for refusal to enroll

    Investigators will record the reasons participants opt not to enroll in the study to determine whether there is a trend.

    Baseline (pre-intervention)

  • Number of subjects who adhered to the intervention

    Percent of subjects who completed the sequence of training sessions and retention sessions. Range: 0-100. Higher percentage indicates more completion

    About 2 months

Secondary Outcomes (17)

  • The change in vertical ground reaction force before and after intervention

    Up to 2 months

  • The change in T1ρ MRI relaxation times before and after intervention

    Up to 2 months

  • The change in T1ρ MRI relaxation times in the medial femoral condyle before and after intervention

    Up to 2 months

  • The change in T1ρ MRI relaxation times in the lateral femoral condyle before and after intervention

    Up to 2 months

  • The change in T1ρ MRI relaxation times in the medial tibial condyle before and after intervention

    Up to 2 months

  • +12 more secondary outcomes

Study Arms (2)

Real-time gait biofeedback (RTGBF)

ACTIVE COMPARATOR

The RTGBF regimen delivers biofeedback that cues a personalized target to normalize vertical ground reaction force (vGRF) of each limb.

Behavioral: Real-time gait biofeedback

Sham real-time gait biofeedback (Sham RTGBF)

SHAM COMPARATOR

The Sham RTGBF regimen will receive biofeedback that cues their habitual step length determined during the accommodation period on the first session of treadmill walking.

Behavioral: Sham real-time gait biofeedback

Interventions

The RTGBF interventions will include eighteen step gait training sessions. The intervention will gradually increase to 3,000 steps at the 9th and 10th session with 100% feedback. During the remaining sessions, the intervention will include 3,000 steps, but the feedback will be gradually tapered off starting with the 11th session.

Real-time gait biofeedback (RTGBF)

The Sham RTGBF interventions will include eighteen step gait training sessions. The intervention will gradually increase to 3,000 steps at the 9th and 10th session with 100% feedback. During the remaining sessions, the intervention will include 3,000 steps, but the feedback will be gradually tapered off starting with the 11th session.

Sham real-time gait biofeedback (Sham RTGBF)

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Have completed all other formal physical therapy
  • Are between the ages of 18 and 35
  • Underwent an ACLR between 6 and 24 months prior to enrollment.
  • Demonstrate underloading during gait (vGRF- impact peak \<1.09 x BW)
  • Demonstrate clinically relevant-knee symptoms (KOOS-QOL \<72)
  • Have undergone ACLR surgery

You may not qualify if:

  • ACLR revision surgery
  • A multiple ligament surgery
  • A lower extremity fracture
  • Knee osteoarthritis
  • The participant has a BMI ≥ 36.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27516, United States

Location

MeSH Terms

Conditions

Anterior Cruciate Ligament InjuriesOsteoarthritis, KneeKnee Injuries

Condition Hierarchy (Ancestors)

Leg InjuriesWounds and InjuriesOsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Brian Pietrosimone

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2021

First Posted

August 16, 2021

Study Start

August 5, 2021

Primary Completion

December 2, 2022

Study Completion

December 2, 2022

Last Updated

April 18, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Time Frame
9 to 36 months
Access Criteria
The investigator who proposes to use the data has approval from an IRB, IEC, or REB, as applicable, and an executed data use/sharing agreement with UNC.

Locations